A recent study indicated that NEAT1 was significantly elevated in the temporal cortex and hippocampus of AD patients (Spreafico et al., 2018), implying that NEAT1 was a biomarker for AD diagnosis. The gene discussed is NEAT1; the disease is Alzheimer disease.